Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
The Food and Drug Administration on Tuesday approved Lannett Co.'s generic allergy treatment.
The Food and Drug Administration on Tuesday approved Abon Pharmaceutical's clofarabine injection.
The Food and Drug Administration on Wednesday placed a clinical hold on Concert Pharmaceuticals' trial for a drug to treat the hair loss condition alopecia areata, reports Reuters.
Many hospitals prefer to dispose unwanted or unneeded medical equipment via a one-stop shop. However, hospitals should dig a little deeper to find companies that will work with them on liquidating specific assets to increase their bottom line, says Gary…
Merck & Co. and Upsher-Smith Laboratories will pay $60.2 million to settle a class action lawsuit alleging the companies participated in a pay-for-delay deal to keep a generic version of the potassium supplement K-Dur off the market, reports Reuters.
While the Food and Drug Administration prioritizes drugs that fill a previously unmet medical need, "me too" drugs — or medications for illnesses that already have treatments — are valuable for lowering high drug costs, says Avik Roy, a healthcare…
After reviewing the results of two large clinical trials, the Food and Drug Administration on Tuesday concluded the Type 2 diabetes treatment canagliflozin leads to increased risk of leg and foot amputations.
The Senate Committee on Health, Education, Labor and Pensions on May 11 advanced the Food and Drug Administration's proposed user fee reauthorization bill with a 21-2 vote, reports Regulatory Focus.
Pharmacy benefit manufacturers complicate the drug pricing system and drive up out-of-pocket costs for patients, according to a new report from Pacific Research Institute.
President Donald Trump's administration may be developing a way to lower prescription drug costs without Congress' involvement, reports The Hill.